The goal of the NCDDG Program is to advance the discovery, preclinical development, and early proof of concept testing in humans of new pharmacologic and neuromodulatory approaches to treat mental disorders, substance use disorders (SUDs), or alcohol addiction, and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets.
from NIMH News Feed http://bit.ly/2KqGprz
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment